Piramal Healthcare’s Q1 net registers 51% growth

03 Aug 2011 Evaluate

Piramal Healthcare, country’s largest drug maker, has reported results for the quarter ended June 30, 2011.

The Company’s net profit for the quarter has registered growth of 51.08% at Rs 101.09 crore whereas the same was at Rs 66.91 crore for the quarter ended June 30, 2010. Its total income has dropped by 44.17% at Rs 334.83 crore for the quarter under review whereas the same was at Rs 599.73 crore for the corresponding quarter of the previous year.

However, the company has reported that its standalone numbers for the quarter ended June 30, 2011 are not comparable to the previous quarter ended June 30, 2010 on account of the sale of domestic formulation business.

On Consolidated basis, the Group’s net profit grew by 10.52% at Rs 89.23 crore for the quarter ended June 30, 2011 whereas the same was at Rs 80.74 crore for the quarter ended June 30, 2010. Its total Income has dropped by 40.90% at Rs 511.96 crore for the quarter whereas the same was at Rs 866.22 crore for the corresponding quarter of the previous fiscal.

Further, the company has reported that its consolidated numbers for the quarter ended June 30, 2011 are not comparable to the previous quarter on account of the sale of Domestic formulation business and Diagnostics Services.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 1018.50
Shriram Finance 1070.25
Aditya Birla Capital 349.50
Chola Invest & Fin. 1709.50
Tata Capital 354.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×